HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.

A study by researchers associated with the University of Kentucky has found most CBD gummies analysed have inaccurate product labeling. Labeling issues have plagued the USA's CBD industry for years, ...

Oral mucosal lesions present significant therapeutic challenges due to the complex oral environment and limitations of conventional biomaterials in clinical application. In this study, we introduced ...